PDL BioPharma, Inc. Goodwill and Intangible Assets (Total)

Goodwill and Intangible Assets (Total) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Goodwill and Intangible Assets (Total) growth rates and interactive chart. The sum of goodwill and all other intangible assets. Intangible assets are items that a company owns and derives benefit from, but is unable to physically measure and count. Examples of intangible assets include patents, trademarks and copyrights. Goodwill is a special type of intangible asset that normally appears in a company's balance sheet following a business combination. When the fair value of the consideration paid by the purchaser for an entity exceeds the fair value of the net assets they have acquired, the purchaser must recognize the resulting difference as goodwill in their balance sheet.


Highlights and Quick Summary

  • Goodwill and Intangible Assets (Total) for the quarter ending June 29, 2020 was $12.6 Million (a -2.59% decrease compared to previous quarter)
  • Year-over-year quarterly Goodwill and Intangible Assets (Total) decreased by -96.53%
  • Annual Goodwill and Intangible Assets (Total) for 2019 was $289 Million (a -32.33% decrease from previous year)
  • Annual Goodwill and Intangible Assets (Total) for 2018 was $428 Million (a -24.28% decrease from previous year)
  • Annual Goodwill and Intangible Assets (Total) for 2017 was $565 Million (a -10.43% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Goodwill and Intangible Assets (Total) of PDL BioPharma, Inc.

Most recent Goodwill and Intangible Assets (Total)of PDLI including historical data for past 10 years.

Interactive Chart of Goodwill and Intangible Assets (Total) of PDL BioPharma, Inc.

PDL BioPharma, Inc. Goodwill and Intangible Assets (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $12.55 $12.88
2019 $13.19 $361.29 $366.09 $425.89 $289.49
2018 $427.83 $431.19 $389.64 $554.88 $427.83
2017 $565.05 $574.04 $571.31 $516.33 $565.05
2016 $630.86 $637.88 $339.34 $354.88 $630.86
2015 $399.2 $384.57 $280.73 $269.67 $399.2
2014 $259.24 $242.45 $247.12 $223.75 $259.24
2013 $235.68 $235.68

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.